HALISTER: Soaring Cost, Toxic Effects Drive Race for Better Cancer Tests

Soaring Cost, Toxic Effects Drive Race for Better Cancer Tests

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
BMY US (Bristol-Myers Squibb Co)

People
Briggs Morrison (AstraZeneca PLC)
Daniel O'Day (Roche Pharma AG)
Leonard Saltz (Memorial Sloan-Kettering Center)
Richard Pazdur (HHS Food & Drug Administration)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283